No Data
No Data
Johnson & Johnson, Amgen Share Losses Contribute To Dow's 100-Point Drop
Nvidia, Apple, Tesla, Walmart, Pfizer, Delta, Peabody Energy, Ford: Biggest Movers
This Johnson & Johnson Analyst Turns Bullish On Shifting Focus From Stelara Concerns To Innovative Medicine
Merck, Goldman Sachs Share Losses Lead Dow's 166-Point Fall
U.S. stock market trends | Biopharmaceutical stocks broadly declined, with Johnson & Johnson (JNJ.US) at one point falling 5.7%.
On Wednesday, biotechnology stocks experienced widespread declines.
Express News | Gilead Sciences Down 4.6%, Amgen Down 2.8%, Pfizer Down 4.2%, Johnson & Johnson Down 3.1%
noob_tradee : hmmm ... that's one of strong support but with new counter tariff from China, gonna be pretty ugly....